Enovis Bullish on Second Half Despite Tougher Comps
The company grew in the mid-teens for the second quarter of 2023 and raised full-year guidance despite tougher comps in the second half. Aug 14, 2023
Orthofix’s Integration Efforts Go Smoothly in First Half
The company grew in the mid-single-digits on a pro forma basis for the second quarter of 2023 as it embarks on its integration plan. Aug 14, 2023
Globus Medical’s Focus Leads to Record Revenues
The company grew in the double-digits for the second quarter of 2023 as it hit records for both total sales and enabling tech sales. Aug 09, 2023
Smith+Nephew Benefits from Elective Procedure Volumes
The company grew in the mid-single digits for 2Q23 as improving operational execution allowed it to leverage elevated orthopedic volumes. Aug 08, 2023
ATEC Keeps Rapid Growth Pace Despite Growing Sales Base
The company grew nearly 40% in the second quarter of 2023 on the strength of its spine focus and lateral procedural solutions. Aug 08, 2023
NuVasive Remains Focused on Strategic Plan
The company grew in the low single digits for the second quarter of 2023 but remains on track to achieve its overall sales guidance. Aug 07, 2023
Stryker Expects Volume Tailwind Well Into 2024
The company grew in the high single digits for the second quarter of 2023 on the strength of its joint replacement and trauma businesses. Aug 07, 2023
Paragon 28 Maintains Growth Pace Despite Supply Pinch
The company grew 20% in the second quarter of 2023 despite supply constraints on some of its newest products. Aug 07, 2023
ZimVie Bolsters International Presence
The company declined in the high single digits in the second quarter of 2023, but found international success with differentiated products. Aug 07, 2023
Zimmer Biomet Exceeding Expectations So Far in 2023
The company grew in the mid-single-digits in the second quarter of 2023 as improved execution and new products offset macro challenges. Aug 03, 2023
